GT Biopharma
Price & Volume
Stats
See more52W Range | $0.54-$4.10 |
Market Cap | $8.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.50 |
News
See moreYahoo Finance • 14 days ago
GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 3 months ago
Friday's after hours session: top gainers and losers
Yahoo Finance • 3 months ago
GT Biopharma Reports Second Quarter 2025 Financial Results
Yahoo Finance • 4 months ago
GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2
About
CEO | Mr. Michael Martin Breen L.L.B. |
CFO | Mr. Alan Louis Urban CPA |
Address | 315 Montgomery Street, San Francisco, CA, United States, 94104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |
